Orthofix Medical Company Insiders
OFIX Stock | USD 17.51 0.64 3.53% |
Orthofix Medical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Orthofix Medical stock suggests that vertually all insiders are panicking at this time. Orthofix Medical employs about 1.6 K people. The company is managed by 22 executives with a total tenure of roughly 24 years, averaging almost 1.0 years of service per executive, having 74.27 employees per reported executive.
Kimberley Elting President President Orthopedics |
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-02-03 | Geoffrey C Gillespie | Disposed 767 @ 17.79 | View | ||
2025-01-16 | Julie Andrews | Disposed 4655 @ 17.89 | View | ||
2025-01-13 | Massimo Calafiore | Disposed 9203 @ 17.14 | View | ||
2025-01-10 | Massimo Calafiore | Disposed 10078 @ 16.83 | View | ||
2025-01-07 | Geoffrey C Gillespie | Disposed 238 @ 17.14 | View | ||
2024-12-17 | Geoffrey C Gillespie | Disposed 26 @ 17.84 | View |
Monitoring Orthofix Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Orthofix |
Orthofix Medical's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Orthofix Medical's future performance. Based on our forecasts, it is anticipated that Orthofix will maintain a workforce of slightly above 1630 employees by March 2025.Orthofix Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.0237) % which means that it has lost $0.0237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2086) %, meaning that it created substantial loss on money invested by shareholders. Orthofix Medical's management efficiency ratios could be used to measure how well Orthofix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.45 in 2025. Return On Capital Employed is likely to rise to -0.2 in 2025. At this time, Orthofix Medical's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 609.6 M in 2025, whereas Intangible Assets are likely to drop slightly above 57.1 M in 2025.Common Stock Shares Outstanding is likely to rise to about 44.4 M in 2025, despite the fact that Net Loss is likely to grow to (16.9 M).
Orthofix Medical Workforce Comparison
Orthofix Medical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 31,180. Orthofix Medical holds roughly 1,634 in number of employees claiming about 5% of equities under Health Care industry.
Orthofix Medical Profit Margins
The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.59 | 0.6513 |
|
|
Orthofix Medical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthofix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthofix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Orthofix Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-06-01 | 1.7143 | 12 | 7 | 426,029 | 132,224 |
2024-03-01 | 0.8462 | 11 | 13 | 310,214 | 452,893 |
2023-12-01 | 2.25 | 9 | 4 | 423,395 | 9,569 |
2023-09-01 | 0.25 | 1 | 4 | 7,500 | 44,545 |
2023-06-01 | 0.625 | 5 | 8 | 44,221 | 23,132 |
2023-03-01 | 1.95 | 39 | 20 | 1,619,831 | 106,796 |
2022-06-01 | 0.8462 | 11 | 13 | 113,273 | 14,233 |
2022-03-01 | 5.0 | 10 | 2 | 309,836 | 9,035 |
2021-12-01 | 3.0 | 6 | 2 | 37,180 | 3,353 |
2021-09-01 | 0.2 | 1 | 5 | 22,184 | 3,579 |
2021-06-01 | 1.8 | 18 | 10 | 224,423 | 12,684 |
2020-09-01 | 0.2222 | 2 | 9 | 43,569 | 5,122 |
2020-06-01 | 2.75 | 22 | 8 | 399,621 | 19,613 |
2019-12-01 | 7.0 | 7 | 1 | 168,938 | 5,142 |
2019-09-01 | 0.3182 | 7 | 22 | 97,826 | 48,311 |
2019-06-01 | 2.5455 | 28 | 11 | 211,083 | 27,730 |
2019-03-01 | 0.625 | 5 | 8 | 32,925 | 52,551 |
2018-12-01 | 0.1429 | 2 | 14 | 11,300 | 48,139 |
2018-09-01 | 1.0 | 12 | 12 | 43,527 | 30,795 |
2018-06-01 | 2.9 | 29 | 10 | 308,105 | 128,255 |
2017-09-01 | 5.1667 | 31 | 6 | 265,542 | 30,111 |
2017-06-01 | 0.5 | 2 | 4 | 28,967 | 57,483 |
2016-12-01 | 1.0 | 2 | 2 | 39,820 | 9,538 |
2016-09-01 | 8.5 | 34 | 4 | 332,376 | 50,000 |
2016-06-01 | 0.6154 | 8 | 13 | 134,712 | 218,168 |
2016-03-01 | 0.0625 | 1 | 16 | 30,000 | 94,025 |
2015-06-01 | 32.0 | 32 | 1 | 355,250 | 5,709 |
2014-06-01 | 13.5 | 27 | 2 | 305,546 | 32,000 |
2013-09-01 | 7.0 | 14 | 2 | 142,750 | 10,000 |
2013-03-01 | 4.5 | 9 | 2 | 176,971 | 26,667 |
2012-12-01 | 0.125 | 1 | 8 | 3,500 | 28,500 |
2012-09-01 | 1.2083 | 29 | 24 | 222,455 | 101,413 |
2012-06-01 | 1.2222 | 11 | 9 | 211,917 | 70,095 |
2011-12-01 | 1.5 | 6 | 4 | 47,201 | 42,478 |
2011-06-01 | 2.0 | 2 | 1 | 175,000 | 150,000 |
2011-03-01 | 1.2857 | 18 | 14 | 169,297 | 86,941 |
2010-03-01 | 0.8182 | 9 | 11 | 29,864 | 34,425 |
2009-09-01 | 0.625 | 5 | 8 | 80,000 | 166,500 |
2009-06-01 | 7.5 | 15 | 2 | 329,000 | 13,187 |
2008-09-01 | 0.5455 | 6 | 11 | 202,625 | 84,000 |
2008-06-01 | 4.7778 | 43 | 9 | 387,180 | 58,875 |
2007-12-01 | 0.4286 | 3 | 7 | 190,000 | 25,000 |
2007-09-01 | 0.1304 | 3 | 23 | 32,500 | 45,000 |
2007-06-01 | 0.3261 | 15 | 46 | 114,600 | 82,674 |
2006-12-01 | 1.0 | 2 | 2 | 32,000 | 6,000 |
2006-09-01 | 2.5 | 5 | 2 | 8,676 | 8,350 |
2006-03-01 | 0.1875 | 3 | 16 | 4,834 | 39,668 |
2005-06-01 | 0.4444 | 20 | 45 | 146,100 | 147,600 |
2005-03-01 | 3.0 | 3 | 1 | 90,000 | 0.00 |
2004-12-01 | 2.8 | 14 | 5 | 167,100 | 18,500 |
2004-09-01 | 0.5 | 1 | 2 | 12,500 | 12,500 |
2004-06-01 | 0.5556 | 5 | 9 | 45,000 | 61,000 |
2004-03-01 | 0.375 | 3 | 8 | 55,000 | 121,000 |
2003-12-01 | 0.4667 | 7 | 15 | 340,674 | 43,760 |
2003-06-01 | 0.5 | 1 | 2 | 160.00 | 15,000 |
Orthofix Medical Notable Stakeholders
An Orthofix Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Orthofix Medical often face trade-offs trying to please all of them. Orthofix Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Orthofix Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Massimo Calafiore | CEO, President | Profile | |
Kimberley Elting | President Orthopedics | Profile | |
Aviva McPherron | President Quality | Profile | |
Jon Serbousek | President - Global Spine Business | Profile | |
Beau PEng | President Technologies | Profile | |
Tyler Lipschultz | President Biologics | Profile | |
Kevin Kenny | President Business | Profile | |
Douglas Rice | CFO Officer | Profile | |
Geoffrey Gillespie | VP Controller | Profile | |
BA Chemistry | Chief Officer | Profile | |
Julie Dewey | Chief Officer | Profile | |
Andres Cedron | Chief Secretary | Profile | |
Stephanie Walsh | Chief Officer | Profile | |
Ehab Esmail | Regulatory Quality | Profile | |
Lucas Vitale | Chief Officer | Profile | |
Suzanne Armstrong | Chief Officer | Profile | |
Frank Vizesi | Chief Officer | Profile | |
Jill Mason | Interim Counsel | Profile | |
Julie Andrews | Chief Officer | Profile | |
Roberto Donadello | Senior Operations | Profile | |
Mark Quick | Sr Relations | Profile | |
Dan Yarbrough | Vice Relations | Profile |
About Orthofix Medical Management Performance
The success or failure of an entity such as Orthofix Medical often depends on how effective the management is. Orthofix Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Orthofix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Orthofix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.47) | (0.45) | |
Return On Capital Employed | (0.21) | (0.20) | |
Return On Assets | (0.48) | (0.45) | |
Return On Equity | (0.29) | (0.28) |
Please note, the imprecision that can be found in Orthofix Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orthofix Medical. Check Orthofix Medical's Beneish M Score to see the likelihood of Orthofix Medical's management manipulating its earnings.
Orthofix Medical Workforce Analysis
Traditionally, organizations such as Orthofix Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Orthofix Medical within its industry.Orthofix Medical Manpower Efficiency
Return on Orthofix Medical Manpower
Revenue Per Employee | 456.9K | |
Revenue Per Executive | 33.9M | |
Net Loss Per Employee | 92.7K | |
Net Loss Per Executive | 6.9M | |
Working Capital Per Employee | 156.2K | |
Working Capital Per Executive | 11.6M |
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.